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expressing Oct3/4, Sox2, c-Myc, and Klf4.
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To generate the CHOPWT9 cell line, four reprogramming factors
(Oct3/4, Sox2, c-Myc, and Klf4) were delivered to PBMCs by Sendai
viral infection. The Sendai virus is non-integrating and the absence of
reprogramming genes in the cells was conﬁrmed by PCR analysis
(Fig. 1A).
DNA ﬁngerprinting conﬁrmed the genetic relationship of the deriv-
ative cells to the parental cells (Fig. 1B). The iPS cells exhibited normal
karyotype (46, XX) upon G-band analysis (Fig. 1C).
Pluripotency was veriﬁed by gene expression of pluripotent stem
cell markers Oct4, Sox2, Nanog, Rex1, DMNT3B and ABCG2 by qPCR
(Fig. 1D). In addition, pluripotent surface marker expression at single
cell resolution of SSEA3, SSEA4, Tra-1-60, and Tra-1-81 was conﬁrmed. This is an open access article underby ﬂow cytometry (Fig. 1E). Differentiation capacity into the three
germ layers was conﬁrmed by in vivo teratoma formation (Fig. 1F).
2. Materials and methods
2.1. Blood sample collection and processing
Blood samples were collected from a healthy adult female into BD
Vacutainer cell preparation tubes (CPT). The PBMCs were isolated by
centrifugation at 1800 rcf for 30 min, after which mononuclear cells
were transferred to a fresh tube, washed with PBS, and centrifuged at
300 rcf for 10 min. Cells were resuspended in freezing medium (90%
FBS, 10% DMSO) and stored in liquid nitrogen. Blood collection was
approved by the CHOP Institutional Review Board committee with
written informed consent.
2.2. iPS cell reprogramming
The PBMCs were expanded and reprogrammed as previously de-
scribed (Yang et al., 2012). Brieﬂy, PBMCs were expanded in QBSF-60
medium containing EPO (2 U/mL), IGF-1 (40 ng/mL), SCF (50 ng/mL),
IL-3 (10 ng/mL), dexamethasone (1.5 μM), ascorbic acid (50 ng/mL),
glutamine (1%), and penicillin/streptomycin (1%) for 7 days. Cells
were transduced with Sendai viral vectors expressing human Oct3/4,
Sox2, Klf4, and c-Myc. (Life Technologies) (MOI according to
manufacturer's instructions). Transduced cells were plated on culture
dishes containing irradiated mouse embryonic ﬁbroblasts (MEFs), and
maintained in human embryonic stem cell medium (HES) containing
5 ng/mL of bFGF. The medium was replenished every 2–3 days for
3 weeks. Cells were maintained in these conditions until uniform colo-
nies were generated and iPS cell colonies were mechanically isolated
for expansion on MEFs.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Generation and characterization of CHOPWT9. (A) PCR analysis showing the absence of reprogramming genes following 20 passages of CHOPWT9. GAPDH was used as a loading
control and post-Sendai virus infected cells were used as a positive control. (B) DNA ﬁngerprinting of CHOPWT9 iPS cells compared to parental cells. (C) Karyotype analysis of CHOPWT9.
(D) Quantitative PCR of relative gene expression of pluripotency genes compared to embryonic stem cells (H9 and CHB8) and a control iPS cell line (CHOPWT6). (E) Flow cytometry pro-
ﬁles showing pluripotent surface markers of CHOPWT9 cells. (F) H&E staining of teratoma sections identifying the three germ layers.
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Conﬁrmation of the genetic integrity of the iPS cell line to the paren-
tal cells were established by DNA ﬁngerprinting. PCR ampliﬁcation was
performed on genomic DNA isolated from parental and iPS cells using
reference primer sets (Ban et al., 2011; Park et al., 2011; Dirks et al.,
1999). Products were separated on a 3.0% agarose gel and visualized
with ethidium bromide.
2.4. Karyotype analysis
Chromosomal G-band analyses were performed in the Genomics
Core Laboratory at CHOP.
2.5. RT-PCR and quantitative PCR
RNA was isolated from the CHOPWT9 iPS cells using the RNeasy
micro kit (Qiagen) according to the manufacturer's instructions. Re-
verse transcription was performed on total RNA (500 ng) using random
hexamerswith Superscript III Reverse Transcriptase (Life Technologies).
The cDNAwas used as a template for PCR ampliﬁcation of the viral back-
bone and reprogramming genes (SeV, Klf4, Oct3/4, Sox2, and c-Myc).
Primer sequences were provided by the company (Life Technologies).
PCR products were separated on a 2.0% agarose gel and visualized
with ethidium bromide. RT-qPCR was performed on a LightCycler-
480II (Roche, IN). All experiments were performed in triplicate using
SYBR-Green qPCR supermix (Roche) according to the manufacturer's
instructions. Primers for all endogenous genes were prepared as
previously described (Mills et al., 2013). Human genomic DNA, diluted
in 10-fold increments from 1 to 100 ng/μL, was used to generate a stan-
dard curve to determine PCR efﬁciency and relative gene expression
compared to the housekeeping gene TBP (TATA Binding Box Protein).
2.6. Flow cytometry analysis
Expression of pluripotency markers was evaluated by ﬂow cytome-
try using the following antibodies: Alexa-Fluor®-647 α-human SSEA4(1:400) and Tra-1-81 (1:200); Alexa-Fluor®-488 SSEA3 (1:200) and
Tra-1-60 (1:200) (BioLegend). Accutase-dissociated single cells were
analyzed using a FACSCanto ﬂow cytometer (BD Biosciences) and the
FlowJo software program (Tree Star, CA).
2.7. In vivo teratoma formation
CHOPWT9 cells were cultured in feeder-free conditions and dissoci-
ated using trypsin. Single cells (~106) were resuspended in medium
containing growth-factor reduced matrigel (100 μL of 1:3 dilution in
IMDM) (Corning) and injected subcutaneously in the neck of NOD/
SCID mice. After 6–8 weeks, teratomas were excised and ﬁxed in 4%
phosphate-buffered formalin for 24 h. The ﬁxed samples were parafﬁn
embedded and stained using hematoxylin and eosin (H&E) for histolog-
ical analysis. This workwas approved by the IACUC committee at CHOP.
References
Ban, H., Nishishita, N., Fusaki, N., Tabata, T., Saeki, K., Shikamura, M., Takada, N., Inoue, M.,
Hasegawa, M., Kawamata, S., Nishikawa, S., 2011. Efﬁcient generation of transgene-
free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai
virus vectors. PNAS 108 (34), 14234–14239.
Dirks, W., MacLeod, R.A., Jäger, K., Milch, H., Drexler, H.G., 1999. First searchable database
for DNA proﬁling of human cell lines: sequential use of ﬁngerprint technique for au-
thentication. Cell. Mol. Biol. 45 (6), 841–853.
Mills, J.A., Wang, K., Paluru, P., Ying, L., Lu, L., Galvão, A.M., Xu, D., Yao, Y., Sullivan, S.K.,
Sullivan, L.M., Mac, H., Omari, A., Jean, J.-C., Shen, S., Gower, A., Spira, A.,
Mostoslavsky, G., Kotton, D.N., French, D.L., Weiss, M.J., Gadue, P., 2013. Clonal genetic
and hematopoietic heterogeneity among human-induced pluripotent stem cell lines.
Blood 122, 2047–2051.
Park, J.H., Daheron, L., Kantarci, S., Lee, B.S., Teixeira, J.M., 2011. Human endometrial cells
express elevated levels of pluripotent factors and are more amenable to
reprogramming into induced pluripotent stem cells. Endocrinology 152 (3),
1080–1089.
Yang, W., Mills, J.A., Sullivan, S., Liu, Y., French, D.L., Gadue, P., 2012. iPSC Reprogramming
fromHuman Peripheral Blood Using Sendai VirusMediated Gene Transfer. Stembook.
